{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:31:43Z","timestamp":1780551103158,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["B40414"],"award-info":[{"award-number":["B40414"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3556-0","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T14:36:30Z","timestamp":1544625390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Augustina","family":"Frimpong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laty Gaye","family":"Thiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Arko-Boham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewurama Dedea Ampadu","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George O.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"3","key":"3556_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/MOH.0b013e328351c35f","volume":"19","author":"P Bartolucci","year":"2012","unstructured":"Bartolucci P, Galacteros F. Clinical management of adult sickle-cell disease. Curr Opin Hematol. 2012;19(3):149\u201355.","journal-title":"Curr Opin Hematol"},{"key":"3556_CR2","unstructured":"WHO. Sickle-cell anaemia. In. Edited by A59\/9. R. Geneva: WHO; 2006."},{"issue":"5","key":"3556_CR3","first-page":"502","volume":"68","author":"DA Diallo","year":"2008","unstructured":"Diallo DA, Baby M, Boire A, Diallo YL. Management of pain of acute sickle cell pain crises by health care providers in Mali. Med Trop (Mars). 2008;68(5):502\u20136.","journal-title":"Med Trop (Mars)"},{"issue":"1","key":"3556_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1086\/430744","volume":"192","author":"TN Williams","year":"2005","unstructured":"Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, Snow RW, Marsh K. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis. 2005;192(1):178\u201386.","journal-title":"J Infect Dis"},{"issue":"6","key":"3556_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1046\/j.1365-3156.1997.d01-322.x","volume":"2","author":"JR Aluoch","year":"1997","unstructured":"Aluoch JR. Higher resistance to Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Tropical Med Int Health. 1997;2(6):568\u201371.","journal-title":"Tropical Med Int Health"},{"key":"3556_CR6","first-page":"5","volume":"10","author":"R Maharajan","year":"1983","unstructured":"Maharajan R, Fleming AF, Egler LJ. Pattern of infections among patients with sickle cell anemia requiring hospital admission. Niger J Paediatr. 1983;10:5.","journal-title":"Niger J Paediatr"},{"issue":"1","key":"3556_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/004947550103100109","volume":"31","author":"JP Ambe","year":"2001","unstructured":"Ambe JP, Fatunde JO, Sodeinde OO. Associated morbidities in children with sickle-cell anaemia presenting with severe anaemia in a malarious area. Trop Dr. 2001;31(1):26\u20137.","journal-title":"Trop Dr"},{"issue":"2","key":"3556_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2009-07-233528","volume":"115","author":"J Makani","year":"2010","unstructured":"Makani J, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, Magesa P, Rwezaula S, Meda E, Mgaya J, et al. Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood. 2010;115(2):215\u201320.","journal-title":"Blood"},{"issue":"10","key":"3556_CR9","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1182\/blood-2010-01-265249","volume":"116","author":"CF McAuley","year":"2010","unstructured":"McAuley CF, Webb C, Makani J, Macharia A, Uyoga S, Opi DH, Ndila C, Ngatia A, Scott JA, Marsh K, et al. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood. 2010;116(10):1663\u20138.","journal-title":"Blood"},{"issue":"1","key":"3556_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0268-960X(89)90022-2","volume":"3","author":"AF Fleming","year":"1989","unstructured":"Fleming AF. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev. 1989;3(1):18\u201328.","journal-title":"Blood Rev"},{"key":"3556_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/bmj.2.5763.710-d","volume":"2","author":"FID Konotey-Ahulu","year":"1971","unstructured":"Konotey-Ahulu FID. Malaria and sickle-cell disease. Br Med J. 1971;2:763.","journal-title":"Br Med J"},{"key":"3556_CR12","doi-asserted-by":"crossref","unstructured":"Konotey-Ahulu FID, Serjeant G, White JM. Treatment and prevention of sickle cell crisis. Lancet. 1971;2(7736).","DOI":"10.1016\/S0140-6736(71)90563-0"},{"key":"3556_CR13","unstructured":"WHO. Sickle-Cell Disease: A strategy for the WHO African Region Report of the Regional Director. In: Sixtieth session. Malabo: Equatorial Guinea; 2010. p. 30."},{"issue":"8","key":"3556_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.curtheres.2003.09.003","volume":"64","author":"FU Eke","year":"2003","unstructured":"Eke FU, Anochie I. Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study. Curr Ther Res Clin Exp. 2003;64(8):616\u201325.","journal-title":"Curr Ther Res Clin Exp"},{"key":"3556_CR15","first-page":"CD003489","volume":"3","author":"O Oniyangi","year":"2003","unstructured":"Oniyangi O, Omari AA. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev. 2003;3:CD003489.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3556_CR16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/tmi.12056","volume":"18","author":"EC Aneni","year":"2013","unstructured":"Aneni EC, Hamer DH, Gill CJ. Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease. Tropical Med Int Health. 2013;18(3):313\u201327.","journal-title":"Tropical Med Int Health"},{"key":"3556_CR17","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovi\u0107 J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.","journal-title":"Bmj"},{"key":"3556_CR18","first-page":"23","volume":"18","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G, Krahn U, Jochem K\u00f6nig J. Package'netmeta', version 0.8\u20130, network meta-analysis using frequentist methods. R Library. Repository CRAN. 2015;18:23.","journal-title":"Repository CRAN"},{"issue":"4","key":"3556_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/infdis\/jiv093","volume":"212","author":"R Olaosebikan","year":"2015","unstructured":"Olaosebikan R, Ernest K, Bojang K, Mokuolu O, Rehman AM, Affara M, Nwakanma D, Kiechel JR, Ogunkunle T, Olagunju T, et al. A randomized trial to compare the safety, tolerability, and effectiveness of 3 antimalarial regimens for the prevention of malaria in Nigerian patients with sickle cell disease. J Infect Dis. 2015;212(4):617\u201325.","journal-title":"J Infect Dis"},{"issue":"1","key":"3556_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00277-010-1040-z","volume":"90","author":"S Diop","year":"2011","unstructured":"Diop S, Soudre F, Seck M, Gueye YB, Dieye TN, Fall AO, Sall A, Thiam D, Diakhate L. Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients-a randomized placebo-controlled trial. Ann Hematol. 2011;90(1):23\u20137.","journal-title":"Ann Hematol"},{"key":"3556_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-8-237","volume":"8","author":"V Nakibuuka","year":"2009","unstructured":"Nakibuuka V, Ndeezi G, Nakiboneka D, Ndugwa CM, Tumwine JK. Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial. Malar J. 2009;8:237.","journal-title":"Malar J"},{"issue":"8","key":"3556_CR22","first-page":"8","volume":"21","author":"C Nwokolo","year":"2001","unstructured":"Nwokolo C, Wambebe C, Akinyanju O, Raji AA, Audu BS, Emodi IJ, Balogun MO, Chukwuani CM. Mefloquine versus Proguanil in short-term malaria chemoprophylaxis in sickle cell Anaemia. Clin Drug Invest 2. 2001;21(8):8.","journal-title":"Clin Drug Invest 2"},{"issue":"5453","key":"3556_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/bmj.2.5453.86","volume":"2","author":"MA Warley","year":"1965","unstructured":"Warley MA, Hamilton PJ, Marsden PD, Brown RE, Merselis JG, Wilks N. Chemoprophylaxis of homozygous Sicklers with Antimalarials and long-acting penicillin. Br Med J. 1965;2(5453):86\u20138.","journal-title":"Br Med J"},{"issue":"2","key":"3556_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1086\/321817","volume":"33","author":"KC Kain","year":"2001","unstructured":"Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis. 2001;33(2):226\u201334.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3556_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00228-003-0652-9","volume":"59","author":"R McGready","year":"2003","unstructured":"McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol. 2003;59(7):545\u201352.","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3556_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejps.2009.11.012","volume":"39","author":"JO Soyinka","year":"2010","unstructured":"Soyinka JO, Onyeji CO. Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz. Eur J Pharm Sci. 2010;39(4):213\u20138.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3556_CR27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2125.1987.tb03245.x","volume":"24","author":"Y Wattanagoon","year":"1987","unstructured":"Wattanagoon Y, Taylor RB, Moody RR, Ochekpe NA, Looareesuwan S, White NJ. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol. 1987;24(6):775\u201380.","journal-title":"Br J Clin Pharmacol"},{"issue":"24","key":"3556_CR28","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","volume":"122","author":"D Manwani","year":"2013","unstructured":"Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood. 2013;122(24):3892\u20138.","journal-title":"Blood"},{"issue":"3","key":"3556_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","volume":"12","author":"JT Lin","year":"2010","unstructured":"Lin JT, Juliano JJ, Wongsrichanalai C. Drug-resistant malaria: the era of ACT. Curr Infect Dis Rep. 2010;12(3):165\u201373.","journal-title":"Curr Infect Dis Rep"},{"issue":"6","key":"3556_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and Proguanil resistance-conferring mutations in Plasmodium falciparum Dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. The American Journal of Tropical Medicine and Hygiene. 1995;52(6):565\u20138.","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"3556_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1368-7646(98)80014-9","volume":"1","author":"CV Plowe","year":"1998","unstructured":"Plowe CV, Kublin JG, Doumbo OK. P. Falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resist Updat. 1998;1(6):389\u201396.","journal-title":"Drug Resist Updat"},{"issue":"3","key":"3556_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.actatropica.2005.06.015","volume":"95","author":"CT Happi","year":"2005","unstructured":"Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, et al. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine\u2013pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop. 2005;95(3):183\u201393.","journal-title":"Acta Trop"},{"issue":"11","key":"3556_CR33","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1086\/522985","volume":"45","author":"I Zongo","year":"2007","unstructured":"Zongo I, Dorsey G, Rouamba N, Dokomajilar C, S\u00e9r\u00e9 Y, Rosenthal PJ, Ou\u00e9draogo JB. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007;45(11):1453\u201361.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3556_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S1473-3099(16)30020-2","volume":"16","author":"SB Sirima","year":"2016","unstructured":"Sirima SB, Ogutu B, Lusingu JPA, Mtoro A, Mrango Z, Ouedraogo A, Yaro JB, Onyango KO, Gesase S, Mnkande E, et al. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial. Lancet Infect Dis. 2016;16(10):1123\u201333.","journal-title":"Lancet Infect Dis"},{"issue":"7056","key":"3556_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/bmj.313.7056.525","volume":"313","author":"PJ Barrett","year":"1996","unstructured":"Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ. 1996;313(7056):525\u20138.","journal-title":"BMJ"},{"key":"3556_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1475-2875-13-369","volume":"13","author":"GO Adjei","year":"2014","unstructured":"Adjei GO, Goka BQ, Enweronu-Laryea CC, Rodrigues OP, Renner L, Sulley AM, Alifrangis M, Khalil I, Kurtzhals JA. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria. Malar J. 2014;13:369.","journal-title":"Malar J"},{"key":"3556_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12936-015-0918-6","volume":"14","author":"M Ndounga","year":"2015","unstructured":"Ndounga M, Pembe Issamou M, Casimiro PN, Koukouikila-Koussounda F, Bitemo M, Diassivy Matondo B, Ndounga Diakou LA, Basco LK, Ntoumi F. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study. Malar J. 2015;14:423.","journal-title":"Malar J"},{"issue":"5","key":"3556_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/cid\/cix785","volume":"66","author":"SR Sugiarto","year":"2018","unstructured":"Sugiarto SR, Moore BR, Makani J, Davis TME. Artemisinin therapy for malaria in Hemoglobinopathies: a systematic review. Clin Infect Dis. 2018;66(5):799\u2013804.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3556-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3556-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3556-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T07:36:34Z","timestamp":1720856194000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3556-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3556"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3556-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AF and LGT are supported by a Ph.D. fellowship from a World Bank African Centres of Excellence Grant (ACE02-WACCBIP: Awandare); AF is also supported by the International Development Research Center grant from the African Institute for Mathematical Sciences, Ghana, a recipient of the L\u2019Oreal-UNESCO for Women in Science Grant, the Carnegie Corporation of New York and the University of Ghana BanGA Ph.D. Grant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have read and agreed to the content of this manuscript and its publication upon acceptance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"650"}}